PT  - JOURNAL ARTICLE
AU  - Diab, Adi
AU  - El-Khoueiry, Anthony
AU  - Abdel-Wahab, Reham
AU  - Thomas, Sajeve
AU  - Hall, Evan
AU  - Wu, Kaida
AU  - Maciejewski, Benjamin S
AU  - Mehta, Naveen K
AU  - Liu, Laura
AU  - Michaelson, Jennifer S
AU  - Jones, Jeffrey A
AU  - Sweis, Randy
TI  - 771 A phase 1 study to assess safety, efficacy, pharmacokinetics, and pharmacodynamics of intratumoral CLN-617 (IL2/IL12 fusion protein) combined with pembrolizumab in patients with advanced solid tumors
AID  - 10.1136/jitc-2023-SITC2023.0771
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A866--A866
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A866.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A866.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.